184 related articles for article (PubMed ID: 17049687)
61. Phenotypic and molecular typing of Vibrio cholerae O1 and O139 isolates from India.
Bhowmick TS; Das M; Roy N; Sarkar BL
J Infect; 2007 May; 54(5):475-82. PubMed ID: 17087996
[TBL] [Abstract][Full Text] [Related]
62. Oral cholera vaccine--for whom, when, and why?
Topps MH
Travel Med Infect Dis; 2006 Jan; 4(1):38-42. PubMed ID: 16887724
[TBL] [Abstract][Full Text] [Related]
63. Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate.
Sim JR; Kang SS; Lee D; Yun CH; Han SH
Front Immunol; 2018; 9():55. PubMed ID: 29434590
[TBL] [Abstract][Full Text] [Related]
64. [Controlled results of the oral anticholera vaccine from the Institut Pasteur during the Shaba-Zaire epidemic in 1983].
Dodin A; Masengo B; Loucq C
C R Acad Sci III; 1984; 299(7):205-7. PubMed ID: 6435818
[TBL] [Abstract][Full Text] [Related]
65. Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
Leung T; Matrajt L
PLoS Negl Trop Dis; 2021 May; 15(5):e0009383. PubMed ID: 34014927
[TBL] [Abstract][Full Text] [Related]
66. Field trial of oral cholera vaccine in Vietnam.
Nagaraj K; Babu BV
Lancet; 1997 Apr; 349(9060):1253-4. PubMed ID: 9130971
[No Abstract] [Full Text] [Related]
67. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
Chandrasekhar MR; Krishna BV; Patil AB
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
[TBL] [Abstract][Full Text] [Related]
68. Cholera: developments in prevention and cure.
van Loon FP
Trop Geogr Med; 1993; 45(6):269-73. PubMed ID: 8116056
[TBL] [Abstract][Full Text] [Related]
69. Cholera vaccine will reduce antibiotic use.
Okeke IN
Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
[No Abstract] [Full Text] [Related]
70. Challenges for programmatic implementation of killed whole cell oral cholera vaccines for prevention and control of cholera: a meta-opinion.
Chatterjee P; Kanungo S; Dutta S
Expert Opin Biol Ther; 2018 Sep; 18(9):983-988. PubMed ID: 30107757
[TBL] [Abstract][Full Text] [Related]
71. Oral cholera vaccine development and use in Vietnam.
Anh DD; Lopez AL; Tran HT; Cuong NV; Thiem VD; Ali M; Deen JL; von Seidlein L; Sack DA
PLoS Med; 2014 Sep; 11(9):e1001712. PubMed ID: 25180511
[TBL] [Abstract][Full Text] [Related]
72. High hopes for oral cholera vaccine.
Bull World Health Organ; 2010 Mar; 88(3):165-6. PubMed ID: 20428379
[TBL] [Abstract][Full Text] [Related]
73. [Dukoral. Oral vaccine against cholera].
Stellfeld M
Ugeskr Laeger; 2004 Nov; 166(47):4251-3. PubMed ID: 15587356
[No Abstract] [Full Text] [Related]
74. [Identification and molecular study on vibrio cholerae in sea products].
Chang ZR; Zhang J; Wang DC; Zhong HJ; Xu J; Ran L; Wang MW; Wang ZJ; Kan B
Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jul; 41(4):304-6. PubMed ID: 17959056
[TBL] [Abstract][Full Text] [Related]
75. Emerging Concepts in Cholera Vaccine Design.
Sit B; Fakoya B; Waldor MK
Annu Rev Microbiol; 2022 Sep; 76():681-702. PubMed ID: 35759873
[TBL] [Abstract][Full Text] [Related]
76. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
[TBL] [Abstract][Full Text] [Related]
77. Dynamics of intestinal flora after oral vaccination with inactivated whole-cell/recombinant B subunit O139 cholera vaccine.
Wu HX; Chen Q; Li JD; Huang XF
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):220-2, 225. PubMed ID: 14965834
[TBL] [Abstract][Full Text] [Related]
78. Herd protection and herd amplification in cholera.
Sack DA
J Health Popul Nutr; 2006 Mar; 24(1):1-5. PubMed ID: 16796143
[No Abstract] [Full Text] [Related]
79. Mucosal immune responses to
Leach S
Hum Vaccin Immunother; 2020 Oct; 16(10):2479-2480. PubMed ID: 32176589
[No Abstract] [Full Text] [Related]
80. [Initial controlled clinical trials of an oral anticholera vaccine during the cholera epidemic in the district of Malemba-Nkulu (Shaba-Zaire)].
Bwanga M
Bull Soc Pathol Exot Filiales; 1984; 77(1):13-6. PubMed ID: 6373033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
